Saturday, March 08, 2014

Rosacea News February 2014

1. Mirvaso has been approved across Europe

News today that Mirvaso has gained approval  or Marketing Authorisation as they call it, by the European Commission. This means that Mirvaso is approved for sale and will soon be available across the European Community, at the will and availability of Galderma. So Mirvaso is now approved for sale in Austria, Belgium, Bulgaria, Croatia, Cyprus, […]

2. Nestle now calling the shots at Galderma

Galderma, the biggest pharmaceutical company of interest to rosacea sufferers has had a subtle, but potentially important change in ownership. Galderma was created in 1981 as a joint venture between L’Oréal and Nestlé and is of course known for their prescription products like Metrogel, Oracea and Mirvaso as well as skincare products like Cetaphil. So […]

3. Mysterious PAC-14028 1% Cream for Red Face

An intriguing clinical trial has surfaced for a cream that is so far unknown to rosacea sufferers. The makers of this cream, which is in Phase 2 trials, Amore Pacific Corporation is located in South Korea. Amore Pacific makes impressively expensive cosmetics. I wonder if anyone has tried their premium products? It is encouraging to see them […]

Rosacea News January 2014

1. Mirvaso European Availability by March 2014

A Medscape article today announces that Mirvaso has been granted human approval and should be approved for sale across Europe by March 2014. The initial authorisation to market Mirvaso has been granted and are normally issued 67 days from the adoption of the `Summary of opinion’ Mirvaso Gains CHMP Support for Rosacea Erythema Treatment Miriam […]

2. Afrin (Oxymetazoline) Safe Off Label Drug for a Red Face

This paper from Hospital Pharmacy is giving a guarded approval for the use of Oxymetazoline topically for the redness of rosacea. Even though the FDA has not approved Oxymetazoline as a topical skin treatment, it is approved as a nasal decongestant. Doctors are able to prescribe drugs for off-label use, that is once a drug […]

3. AARS, The Best Rosacea Topicals

The American Acne & Rosacea Society have published another paper in their series looking at the state of the art in rosacea treatments. This part is dedicated to rosacea topicals, and how to use them to manage rosacea symptoms. The paper is described as reviewing “topical agents approved by the US Food and Drug Administration […]

4. Topical Ivermectin 0.5% being trialled for Demodicidosis and rosacea papules

A just listed clinical trial shows a continuing interest in the usage of Topical Ivermectin for rosacea like syptoms. This trial will see how well Ivermectin can treat Demodicidosis and the associated symptoms of redness, dryness, itch, roughness and scaling. What is Demodicidosis? Demodicidosis is a condition where there is an infestation of demodex mites. […]

5. Rosacea coverage at AAD Denver 2014

The annual meeting of the American Academy of Dermatology is to be held in March in Denver, Colorado. The popularity of the  topic of rosacea seems to have waxed and waned over the years. This year there are mentions in keynote and symposium sessions for rosacea. It doesn’t seem like rosacea will have much of […]

6. NeoStrata Facial Cleanser and Ultra Moisturizing Face Cream

Rosacea sufferers are always on the lookup for suitable cleansers and moisturizers. One of the pearls in finding relief from rosacea symptoms is that finding a supporting and gentle cleansing and moisturizing (and protective) regime is important. A recent paper by Dr. Patricia Farris, Skin Care Based on Science: Improving Outcomes in Rosacea, tells us […]

7. Mirvaso Gel Judged Safe and Efficacious Long Term

This just published paper, in the peer-reviewed Journal of Drugs in Dermatology, again asserts that Mirvaso is “efficacious and safe“ for daily use over 1 year. This study details a trial of 345 users over a year, whilst the Mirvaso Prescribing Information quotes results from 276 users over 1 year. The previously published long term […]